penicillamine has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seegmiller, JE | 1 |
| Friedmann, T | 1 |
| Harrison, HE | 1 |
| Wong, V | 1 |
| Schneider, JA | 1 |
1 other study available for penicillamine and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Cystinosis. Combined clinical staff conference at the National Institutes of Health.
Topics: Amino Acid Metabolism, Inborn Errors; Biopsy; Bone Marrow; Child; Chronic Kidney Disease-Mineral and | 1968 |